Health
Start-up receives NIH grant to accelerate development of contrast agent to detect liver fibrosis – News-Medical.Net
Inlighta Biosciences, LLC, a start-up company led by Jenny Yang, Regents’ Professor of Chemistry at Georgia State University, has been awarded a National Instit…
Reviewed by Emily Henderson, B.Sc.Oct 15 2020
Inlighta Biosciences, LLC, a start-up company led by Jenny Yang, Regents’ Professor of Chemistry at Georgia State University, has been awarded a National Institute of Health grant to accelerate development of a magnetic resonance imaging contrast agent to detect liver fibrosis, formation of scar tissue in the liver caused by alcoholic and non-alcoholic fatty liver disease.
We have been working on this breakthrough in the lab for several years. This…
-
Noosa News16 hours agoQueensland weather forecast sees sunny weather for last week of winter
-
General19 hours agoFirst home buyers score early access to deposit scheme
-
Noosa News17 hours agoForum responds to urgent homelessness issues in Nambour
-
General16 hours agoEnergy provider ENGIE to ‘correct’ electricity bills for thousands of South Australian customers